SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-041005
Filing Date
2022-03-31
Accepted
2022-03-31 16:05:44
Documents
14
Period of Report
2022-03-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2211112d1_8k.htm   iXBRL 8-K 35337
2 EXHIBIT 99.1 tm2211112d1_ex99-1.htm EX-99.1 11592
6 GRAPHIC image_001.jpg GRAPHIC 3936
  Complete submission text file 0001104659-22-041005.txt   230341

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA armp-20220330.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20220330_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20220330_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2211112d1_8k_htm.xml XML 3474
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 22792405
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences